AUG 26, 2021 3:00 AM PDT

COVID-19 Vaccination Induces Strong Immunity in Cancer Patients

WRITTEN BY: Katie Kokolus

Cancer patients have a higher risk of developing severe symptoms from a COVID-19 infection.   Many cancer patients undergoing active cancer therapy are immunocompromised, making them even more susceptible to contracting COVID-19. 

Protecting vulnerable populations, including cancer patients, from COVID-19 is a high priority for public health.  Therefore, the efficacy of COVID-19 vaccines is an essential factor for patients and their doctors to consider.

Encouraging data published recently by a team of researchers in JAMA Oncology suggests that most cancer patients who received two doses of the BioNTech-Pfizer mRNA vaccine still retained immunity four months after vaccination.

The researchers measured titers of anti-spike (anti-S) immunoglobulin G (IgG) antibodies against SARS-CoV2 in blood samples from 95 cancer patients with various solid tumors who were undergoing systemic therapy.  The most prevalent cancer types in the study were gastrointestinal, lung, and breast.  Patients received different treatments, including chemotherapy, immunotherapy, and biological therapy.  Some patients received more than one therapy. 

Seropositivity, the presence of a specific marker in the blood, was defined as 50 or greater AU/ml.  Therefore, blood samples deemed positive contained COVID specific antibodies which may protect from COVID-19 infection.  Previous data from the same group of patients found that 92% exhibited seropositivity at an average of 28 days following the second dose of vaccination. 

Approximately four months (an average of 123 days) after the second dose of vaccine, 87% of patients tested positive for anti-S IgG antibodies.  The anti-S IgG titers varied by tumor type and therapy. The research team detected the lowest titers in patients receiving immunotherapy plus chemotherapy/biological therapy.

The study also included 66 healthy controls chosen from caregivers accompanying patients to treatment.  Notably, 100% of the controls tested positive for anti-S IgG antibodies in both the current and previous studies.

While vaccinated patients undergoing cancer treatment generate less anti-S IgG than healthy individuals, the authors conclude that the seropositivity rate remains high for most of these cancer patients up to four months after vaccination. 

 

Sources: severe symptomsJAMA OncologyBioNTech-Pfizer mRNA vaccinePrevious data

About the Author
  • PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUL 08, 2021
Genetics & Genomics
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
JUL 08, 2021
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
Children with Down syndrome have a significantly higher likelihood myeloid leukemia occurring in the first five years of ...
AUG 24, 2021
Technology
CRISPR Helps Identify New Therapeutic Target for Leukemia
AUG 24, 2021
CRISPR Helps Identify New Therapeutic Target for Leukemia
Researchers may have found a new druggable target in patients with acute myeloid leukemia (AML), thanks to a CRISPR scre ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
OCT 21, 2021
Cancer
Exercise: A Secret Weapon to Combat Prostate Cancer?
OCT 21, 2021
Exercise: A Secret Weapon to Combat Prostate Cancer?
Exercise oncology is an evolving science that considers the addition of physical activity regimens to the treatment ...
OCT 14, 2021
Clinical & Molecular DX
Weighing Cancer Cells Helps Predict Treatment Outcomes
OCT 14, 2021
Weighing Cancer Cells Helps Predict Treatment Outcomes
Not all cancer patients respond to oncology treatments in the same way. Some might show signs of improvement as the ther ...
Loading Comments...